Histrelin Acetate (Vantas®)

Common name: Histrelin Acetate
Brand name: Vantas®
 

What is Histerlin Acetate?

Histrelin Acetate is a palliative treatment for men diagnosed with hormone-dependent advanced (metastatic) prostate cancer.
 

How is Histrelin Acetate administered?

Histerlin Acetate is a placed under the skin (subcutaneous) as a subdermal implant.
 

What are possible side effects of this treatment?

Everyone responds differently to hormone therapy – some experience many side effects while others experience very few. Below are some side effects experienced by those who received histrelin. Tell your health care team about side-effects you are experiencing so they know how best to help you manage them.
  • Abdominal pain
  • Dark urine
  • Difficulties breathing
  • Local infection
  • Loss of appetite
  • Nausea
  • Reduced testicle size
  • Vomiting
  • Weight gain
 

Is Histrelin Acetate covered in my province or territory?

Provincial/Territorial Drug Program Coverage: Unknown 
 

 
Last Reviewed: July 2017

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive